Edition:
United Kingdom

AGNC Investment Corp (AGNC.OQ)

AGNC.OQ on NASDAQ Stock Exchange Global Select Market

18.59USD
8:59pm GMT
Change (% chg)

$-0.24 (-1.27%)
Prev Close
$18.83
Open
$18.85
Day's High
$19.06
Day's Low
$18.59
Volume
876,106
Avg. Vol
1,113,008
52-wk High
$22.34
52-wk Low
$17.94

Select another date:

Wed, Jan 31 2018

BRIEF-AGNC Investment Reports Qtrly Earnings Per Share $0.96

* AGNC INVESTMENT CORP. ANNOUNCES FOURTH QUARTER 2017 FINANCIAL RESULTS

BRIEF-Bernice Bell To Be Promoted To Senior VP And CFO of AGNC Investment

* AGNC INVESTMENT CORP - BERNICE BELL WILL BE PROMOTED TO SENIOR VICE PRESIDENT AND CHIEF FINANCIAL OFFICER Source text for Eikon: Further company coverage:

BRIEF-AGNC Investment reports Q3 ‍net interest income $178 mln

* AGNC Investment Corp. Announces third quarter 2017 financial results

IFR Americas ECM Pipeline

Sept 13, 2017 - PRICED AGNC Investment (US, Mortgage REIT) – $510.8m Block. 24.5m shares (100% prim) at $20.85 versus $20.75-$20.95 marketing range and $21.50 last sale. CS, JPM, MS, UBS, WF. BioCryst Pharmaceuticals (US, biotech) – $80m FO. 15.5m (100% prim) at $5.15 versus $5.23 last sale and $5.75 launch JPM, BARC. Grupo Supervielle (Argentina, bank) – $412m FO. 20.6m ADS (68% prim, 32% sec) at $20.00 versus $20.56 last sale and $22.00 at launch. BAML, ITAU, JPM. Portola Pharmaceuticals (US,

BRIEF-AGNC Investment announces pricing of public offering of common stock

* AGNC Investment Corp. announces pricing of public offering of common stock

BRIEF-AGNC Investment announces public offering of 24.5 mln common stock

* AGNC Investment Corp announces public offering of common stock

Select another date: